2.89
0.20 (7.43%)
0.20 (7.43%)
Upgrade to Real-Time
Premarket
| Volume | 450 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Humanigen Inc | HGEN | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.20 | 7.43% | 2.89 | 07:00:03 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.69 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 23 | 450 | - | 2.67 - 29.20 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 07:01:05 | 4 | $ 2.80 | USD |
Period:
Draw Mode:
Humanigen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 184.43M | 63.82M | 42.53M | $ 312.00k | $ - | -2.24 | -0.70 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 108.36k | 0.90% |
Humanigen News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HGEN Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.22 | 3.30 | 2.67 | 2.82 | 1,367,714 | -0.33 | -10.25% |
| 1 Month | 3.74 | 4.20 | 2.67 | 3.48 | 1,603,498 | -0.85 | -22.73% |
| 3 Months | 6.95 | 8.38 | 2.67 | 4.95 | 2,119,817 | -4.06 | -58.42% |
| 6 Months | 15.96 | 18.6473 | 2.67 | 7.22 | 2,163,569 | -13.07 | -81.89% |
| 1 Year | 18.98 | 29.20 | 2.67 | 13.07 | 2,097,096 | -16.09 | -84.77% |
| 3 Years | 10.85 | 29.20 | 2.67 | 13.10 | 1,794,605 | -7.96 | -73.36% |
| 5 Years | 10.85 | 29.20 | 2.67 | 13.10 | 1,794,605 | -7.96 | -73.36% |
Humanigen Description
| Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005. |